Reducing mortality from 2019-nCoV: host-directed therapies should be an option-MedSci.cn

Reducing mortality from 2019-nCoV: host-directed therapies should be an option

Zumla, A; Hui, DS; Azhar, EI; Memish, ZA; Maeurer, M

Maeurer, M (corresponding author), Champalimaud Ctr Unknown, Immunotherapy Programme, P-1400038 Lisbon, Portugal.

LANCET, 2020; 395 (10224): E35